Bedside B-Type natriuretic peptide in the emergency diagnosis of heart failure with reduced or preserved ejection fraction. Results from the Breathing Not Properly Multinational Study
- PMID: 12798574
- DOI: 10.1016/s0735-1097(03)00405-4
Bedside B-Type natriuretic peptide in the emergency diagnosis of heart failure with reduced or preserved ejection fraction. Results from the Breathing Not Properly Multinational Study
Abstract
Objectives: This study examines B-type natriuretic peptide (BNP) levels in patients with systolic versus non-systolic dysfunction presenting with shortness of breath.
Background: Preserved systolic function is increasingly common in patients presenting with symptoms of congestive heart failure (CHF) but is still difficult to diagnose.
Methods: The Breathing Not Properly Multinational Study was a seven-center, prospective study of 1,586 patients who presented with acute dyspnea and had BNP measured upon arrival. A subset of 452 patients with a final adjudicated diagnosis of CHF who underwent echocardiography within 30 days of their visit to the emergency department (ED) were evaluated. An ejection fraction of greater than 45% was defined as non-systolic CHF.
Results: Of the 452 patients with a final diagnosis of CHF, 165 (36.5%) had preserved left ventricular function on echocardiography, whereas 287 (63.5%) had systolic dysfunction. Patients with non-systolic heart failure (NS-CHF) had significantly lower BNP levels than those with systolic heart failure (S-CHF) (413 pg/ml vs. 821 pg/ml, p < 0.001). As the severity of heart failure worsened by New York Heart Association class, the percentage of S-CHF increased, whereas the percentage of NS-CHF decreased. When patients with NS-CHF were compared with patients without CHF (n = 770), a BNP value of 100 pg/ml had a sensitivity of 86%, a negative predictive value of 96%, and an accuracy of 75% for detecting abnormal diastolic dysfunction. Using Logistic regression to differentiate S-CHF from NS-CHF, BNP entered first as the strongest predictor followed by oxygen saturation, history of myocardial infarction, and heart rate.
Conclusions: We conclude that NS-CHF is common in the setting of the ED and that differentiating NS-CHF from S-CHF is difficult in this setting using traditional parameters. Whereas BNP add modest discriminatory value in differentiating NS-CHF from S-CHF, its major role is still the separation of patients with CHF from those without CHF.
Comment in
-
Natriuretic peptide measurements for the diagnosis of "nonsystolic" heart failure: good news and bad.J Am Coll Cardiol. 2003 Jun 4;41(11):2018-21. doi: 10.1016/s0735-1097(03)00395-4. J Am Coll Cardiol. 2003. PMID: 12798575 No abstract available.
Similar articles
-
The effects of ejection fraction on N-terminal ProBNP and BNP levels in patients with acute CHF: analysis from the ProBNP Investigation of Dyspnea in the Emergency Department (PRIDE) study.J Card Fail. 2005 Jun;11(5 Suppl):S9-14. doi: 10.1016/j.cardfail.2005.04.011. J Card Fail. 2005. PMID: 15948094
-
B-type natriuretic peptide and echocardiographic determination of ejection fraction in the diagnosis of congestive heart failure in patients with acute dyspnea.Chest. 2005 Jul;128(1):21-9. doi: 10.1378/chest.128.1.21. Chest. 2005. PMID: 16002911
-
Uncovering heart failure in patients with a history of pulmonary disease: rationale for the early use of B-type natriuretic peptide in the emergency department.Acad Emerg Med. 2003 Mar;10(3):198-204. doi: 10.1111/j.1553-2712.2003.tb01990.x. Acad Emerg Med. 2003. PMID: 12615582
-
[Plasma brain natriuretic peptide as a useful biochemical marker of congestive heart failure].Nihon Rinsho. 2003 May;61(5):782-8. Nihon Rinsho. 2003. PMID: 12755003 Review. Japanese.
-
[Brain natriuretic peptide].Rinsho Byori. 2004 Aug;52(8):655-68. Rinsho Byori. 2004. PMID: 15478621 Review. Japanese.
Cited by
-
Role of Cardiac Natriuretic Peptides in Heart Structure and Function.Int J Mol Sci. 2022 Nov 20;23(22):14415. doi: 10.3390/ijms232214415. Int J Mol Sci. 2022. PMID: 36430893 Free PMC article. Review.
-
Roles of cMyBP-C phosphorylation on cardiac contractile dysfunction in db/db mice.J Mol Cell Cardiol Plus. 2024 Jun;8:100075. doi: 10.1016/j.jmccpl.2024.100075. Epub 2024 Apr 4. J Mol Cell Cardiol Plus. 2024. PMID: 38957358 Free PMC article.
-
Adiponectin through its biphasic serum level is a useful biomarker during transition from diastolic dysfunction to systolic dysfunction - an experimental study.Lipids Health Dis. 2012 Aug 30;11:106. doi: 10.1186/1476-511X-11-106. Lipids Health Dis. 2012. PMID: 22935137 Free PMC article.
-
Elevated BNP with normal systolic function in asymptomatic individuals at-risk for heart failure: a marker of diastolic dysfunction and clinical risk.Ir J Med Sci. 2006 Oct-Dec;175(4):5-13. doi: 10.1007/BF03167960. Ir J Med Sci. 2006. PMID: 17312822
-
Response of novel biomarkers to BNP infusion in patients with decompensated heart failure: a multimarker paradigm.J Cardiovasc Transl Res. 2009 Dec;2(4):526-35. doi: 10.1007/s12265-009-9121-x. Epub 2009 Aug 14. J Cardiovasc Transl Res. 2009. PMID: 20560012
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Research Materials
Miscellaneous